Anti-inflammatory effects of boron alone or as adjuvant with dexamethasone in animal models of chronic and granulomatous inflammation

Hanaw Ameen, Saad Hussain, Zheen Ahmed, Tavga Aziz
2015 International Journal of Basic & Clinical Pharmacology  
Side effects of anti-inflammatory agents are a major problem during clinical use. The development of a newer, effective, and safe anti-inflammatory agent should be considered. Boron-containing compounds are found effective as anti-inflammatory agents with relatively low side effects. We aimed to evaluate the anti-inflammatory activity of boron in animal models of chronic and granulomatous inflammation. Methods: Sixty-six Wistar rats were allocated into five groups; 1st (6 rats) treated with
more » ... s) treated with vehicle only without induction as a negative control; 2nd (12 rats) allocated into two subgroups, treated with vehicle only, with induction of chronic and granulomatous inflammation, as appositive control. 3rd group (24 rats) allocated into four subgroups, treated with different doses of boron (3 and 6 mg/kg) in both models. Fourth group (12 rats) treated with dexamethasone (1 mg/kg) in the same models. 5th group (12 rats used) treated with boron (3 mg/kg) with dexamethasone (1 mg/kg) in the same models. Results: Boron, in a dose-dependent pattern significantly decreases inflammation in rat models of chronic and granulomatous inflammation. Combination of boron with dexamethasone significantly suppresses inflammation in both models, which is significantly higher than all of the effects produced by other approaches of treatment. Conclusion: Boron, in a dose-dependent pattern, effectively suppresses formaldehyde-induced chronic inflammation and cotton pellet-induced granuloma in rats when used alone or as an adjuvant with dexamethasone. It may be considered as a potential treatment for chronic inflammatory conditions.
doi:10.18203/2319-2003.ijbcp20150376 fatcat:k4qjf3ircffmddw3pvnzu76rqu